Anesthesia and analgesia
-
Anesthesia and analgesia · Jan 2021
Clinical TrialThe Effects of Nitroglycerin on the Oxytocin Dose-Response Profile in Oxytocin-Desensitized and Naïve Human Myometrium: An In Vitro Study.
Nitroglycerin is used for acute reduction in uterine tone. Prolonged oxytocin exposure causes desensitization of oxytocin receptors. It is unknown if nitroglycerin exposure impacts the subsequent action of oxytocin in the setting of oxytocin receptor desensitization. This study investigated the effects of nitroglycerin on oxytocin-desensitized and oxytocin-naïve human myometrium and the subsequent response to oxytocin dose-response testing in vitro. ⋯ Nitroglycerin-induced relaxation was not different between oxytocin-desensitized and oxytocin-naïve human myometrial strips in vitro. However, oxytocin-induced contractility was attenuated after nitroglycerin exposure in both oxytocin-desensitized and oxytocin-naïve samples, with maximum attenuation observed in desensitized tissues. This finding warrants further clinical studies to explore uterine responsiveness to oxytocin in women with oxytocin-augmented labors after nitroglycerin administration.
-
Anesthesia and analgesia · Jan 2021
Observational StudyLung Ultrasound Findings in the Postanesthesia Care Unit Are Associated With Outcome After Major Surgery: A Prospective Observational Study in a High-Risk Cohort.
Postoperative pulmonary complications are associated with increased morbidity. Identifying patients at higher risk for such complications may allow preemptive treatment. ⋯ When lung ultrasound is performed precociously <2 hours after extubation, detection of immediate postoperative alveolar consolidation and pleural effusion by lung ultrasound is associated with postoperative pulmonary complications and morbi-mortality. Further study is needed to determine the effect of ultrasound-guided intervention for patients at high risk of postoperative pulmonary complications.
-
Zdravkovic, Rice and Brull take an objective look at the current evidence for cricoid pressure (CP) and professional guidelines for its use, reiterating the persistent uncertainty and general low-quality of evidence supporting use or avoidance.
They note...
- Sellick's original 1961 description is based upon significantly flawed audit data.
- There is much contradictory primary science research showing some effect of CP.
- NAP4 found pulmonary aspiration responsible for more deaths than intubation or ventilation failures, and the US ASA Closed Claims database shows it to be the third most common pulmonary event leading to claims. Thus recommendations and guidelines for the use of cricoid pressure carry very real medicolegal implications even in the absence of quality clinical evidence.
- Microaspiration in elective surgery is common (20%) but does not appear to be modified by CP.
- CP has a variable effect on the ease of intubation.
- There is no agreement on CP application technique nor even on scenarios where it should or should not be used.
- CP guidelines are variable, based on low-quality evidence and largely dependent on expert opinion.
- CP use is largely up to individual judgement, with a pragmatic approach best adopted for its application or release.
- Perhaps the greatest impact can be gained from ultrasound evaluation of gastric volume to identify those most at risk of aspiration?
Be smart
Bedside risk stratification for pulmonary aspiration is probably the single greatest modifiable factor in anesthesia practice to reduce aspiration, almost certainly of greater importance than the ongoing cricoid pressure debate – which may never be conclusively resolved.
summary -
Anesthesia and analgesia · Jan 2021
Randomized Controlled TrialIntravenous Amisulpride Does Not Meaningfully Prolong the QTc Interval at Doses Effective for the Management of Postoperative Nausea and Vomiting.
Postoperative nausea and vomiting (PONV) are significant issues in surgical patients, and additional treatment options are needed. Dopaminergic antiemetics have been popular for their efficacy, but their use has been limited by safety concerns, especially the potential for torsade de pointes arising from QT interval prolongation. Intravenous (IV) amisulpride, a dopamine D2 and D3 antagonist shown to be effective at preventing and treating PONV at doses of 5 and 10 mg, respectively, has a dose-dependent effect on QT but at 5 mg is not associated with clinically meaningful prolongation of the heart rate-corrected QT (QTc) interval. This study was designed to evaluate the QT effect of a 10-mg dose of amisulpride, alone and when simultaneously coadministered with ondansetron, an antiemetic of a different class, also known to prolong the QT interval. ⋯ A 10-mg dose of IV amisulpride, given alone or in combination with ondansetron, does not have a clinically significant effect on the QT interval.